Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189)

HKG:8189 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	522.97	385.48	398	403.73	476.38
Revenue Growth (YoY)	35.67%	-3.15%	-1.42%	-15.25%	28.98%
Cost of Revenue	487.29	368.51	376.63	388.91	430.78
Gross Profit	35.67	16.97	21.37	14.82	45.6
Selling, General & Admin	32.22	34.26	29.91	33.21	48.76
Research & Development	4.14	1.1	1.32	1.14	3.5
Operating Expenses	38.28	45.35	40.7	39.24	63.99
Operating Income	-2.61	-28.38	-19.34	-24.41	-18.39
Interest Expense	-3.79	-4.58	-5.17	-6.4	-5.47
Interest & Investment Income	-	0.05	0.25	0.76	0.43
Earnings From Equity Investments	-0	-	-	-	1
Currency Exchange Gain (Loss)	-	-	-	-	0.08
Other Non Operating Income (Expenses)	-74.35	-2.6	-2	0.09	-0.38
EBT Excluding Unusual Items	-80.75	-35.52	-26.26	-29.97	-22.73
Impairment of Goodwill	-	-	-	-	-0.42
Gain (Loss) on Sale of Investments	-	-	0	5.96	-
Gain (Loss) on Sale of Assets	-8.22	-0.28	-0.2	-0.05	0.15
Asset Writedown	-23.97	-2.41	-	-	-21.84
Other Unusual Items	-	-	14.44	-	-
Pretax Income	-112.94	-38.21	-12.01	-24.06	-44.84
Income Tax Expense	0.61	-0.22	-1.04	-0.51	-0.05
Earnings From Continuing Operations	-113.54	-37.99	-10.97	-23.55	-44.78
Earnings From Discontinued Operations	-	1.85	-5.6	-2.44	-
Net Income to Company	-113.54	-36.14	-16.57	-25.99	-44.78
Minority Interest in Earnings	22.72	8.34	-3.59	-1.46	2.53
Net Income	-90.82	-27.8	-20.16	-27.45	-42.26
Net Income to Common	-90.82	-27.8	-20.16	-27.45	-42.26
Shares Outstanding (Basic)	-	1,895	1,895	1,895	1,895
Shares Outstanding (Diluted)	-	1,895	1,895	1,895	1,895
EPS (Basic)	-	-0.01	-0.01	-0.01	-0.02
EPS (Diluted)	-	-0.01	-0.01	-0.01	-0.02
Free Cash Flow	-	-28.83	-15.62	-21.62	-34.28
Free Cash Flow Per Share	-	-0.01	-0.01	-0.01	-0.02
Gross Margin	6.82%	4.40%	5.37%	3.67%	9.57%
Operating Margin	-0.50%	-7.36%	-4.86%	-6.05%	-3.86%
Profit Margin	-17.37%	-7.21%	-5.07%	-6.80%	-8.87%
Free Cash Flow Margin	-	-7.48%	-3.92%	-5.36%	-7.20%
EBITDA	4.37	-21.41	-10.45	-14.82	-14.27
EBITDA Margin	0.83%	-5.55%	-2.63%	-3.67%	-3.00%
D&A For EBITDA	6.97	6.97	8.89	9.59	4.12
EBIT	-2.61	-28.38	-19.34	-24.41	-18.39
EBIT Margin	-0.50%	-7.36%	-4.86%	-6.05%	-3.86%
Advertising Expenses	-	1.2	0.57	1.02	2.52

Source: S&P Global Market Intelligence. Standard template. Financial Sources.